| Literature DB >> 33912113 |
Christine Maheu1, Mina Singh2, Wing Lam Tock1, Asli Eyrenci3, Jacqueline Galica4, Maude Hébert5, Francesca Frati6, Tania Estapé7.
Abstract
Objective: Fear of Cancer Recurrence (FCR), Health Anxiety (HA), worry, and uncertainty in illness are psychological concerns commonly faced by cancer patients. In survivorship research, these similar, yet different constructs are frequently used interchangeably and multiple instruments are used in to measure them. The lack of clear and consistent conceptualization and measurement can lead to diverse or contradictory interpretations. The purpose of this scoping review was to review, compare, and analyze the current conceptualization and measurements used for FCR, HA, worry, and uncertainty in the breast cancer survivorship literature to improve research and practice. Inclusion Criteria: We considered quantitative, qualitative, and mixed methods studies of breast cancer survivors that examined FCR, HA, worry, or uncertainty in illness as a main topic and included a definition or assessment of the constructs. Methods and Analysis: The six-staged framework was used to guide the scoping review process. Searches of PubMed, CINAHL, and PsycINFO databases were conducted. The principle-based qualitative analysis and simultaneous content analysis procedures were employed to synthesize and map the findings. Findings: After duplicate removal, the search revealed 3,299 articles, of which 82 studies met the inclusion criteria. Several critical attributes overlapped the four constructs, for example, all were triggered by internal somatic and external cues. However, several unique attributes were found (e.g., a sense of loss of security in the body is observed only among survivors experiencing FCR). Overall, findings showed that FCR and uncertainty in illness are more likely to be triggered by cancer-specific factors, while worry and HA have more trait-like in terms of characteristics, theoretical features, and correlates. We found that the measures used to assess each construct were on par with their intended constructs. Eighteen approaches were used to measure FCR, 15 for HA, 8 for worry, and 4 for uncertainty.Entities:
Keywords: cancer survivorship; conceptualization; fear of cancer recurrence; health anxiety; measurement; scoping review; uncertainty; worry
Year: 2021 PMID: 33912113 PMCID: PMC8072115 DOI: 10.3389/fpsyg.2021.644932
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Study inclusion and exclusion criteria.
| Design | A primary quantitative or qualitative research. We included only the primary research if a secondary analysis of the same set of data was available. | Case report, protocols, reviews of the literature, and conference proceedings |
| Publication types | Peer-reviewed journal; the full article describing the research was available in English. | Commentaries, books, book reviews, letters to the editor, theses, opinion papers, abstracts without full-text, or articles without an English full-text. |
| Participants | Participants must involve women with stage 0–3 breast cancer, ductal carcinoma | The participants in the study had metastatic or recurrent cancer; participants were undergoing genetic testing or counseling, as this was considered to be a form of treatment. |
| Study concepts | Included Fear of Cancer Recurrence (FCR), Health Anxiety (HA), Worry or Uncertainty as a major concept. Fear of progression (FoP) is used interchangeably with FCR; therefore, we included the term FoP in our search and selection process. | The concepts under study included fear of disfigurement, fear of having children, fear of returning to society, etc. |
Figure 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) selection of sources of evidence flow diagram.
Critical attribute categories and coding guidance for categorizing the four psychological constructs.
| Conceptualization of the four constructs is demonstrated in the following four ways: | ||
| • Instruments designed to determine the quantity of a variable within the concepts (i.e., | • “Health anxiety is measured using the |
refer to .
Conceptualization: number and prevalence of thematically derived critical attributes for the four constructs: article numbers reflected in Supplementary Material.
| The concern that cancer will come back or progress | [3] [6] [15] [16] [30] [40] [41] [42] [46] [49] [56] [57] [58] [60] [63] [66] [67] [69] [70] [71] [72] [73] [74] [78] [81] [82] [76] | — | [61] | — |
| A type of cancer-related worry | [17] [30] [32] [33] [34] [41] [49] [70] [79] [81] | — | [17] [41] [61] | — |
| A subset of anxiety | [13] [30] [40] [46] [49] [51] [54] [67] | — | — | — |
| Trait anxiety | — | [6] [40] [48] [62] | — | — |
| State anxiety | — | [6] [40] [48] [62] | — | — |
| A symptomatic consequence of anxiety | — | — | [17] [54] | — |
| A type of emotional reaction | — | — | [61] | — |
| The inability to determine the meaning or outcome of the illness | — | — | — | [10] [25] [26] [52] |
| Being in doubt, being undecided, perceptions of vagueness | — | — | — | [29] [68] |
| A state of liminality | — | — | — | [75] |
| A mismatch between one's expectation and the realistic world | — | — | — | [80] |
| A moderator between triggers and FCR | — | — | — | [41] |
| A trigger of FCR | — | — | — | [10] [12] [25] [26] [27] [41] [52] [55] [56] [80] |
| Excessive seeking of professional advice for reassurance | [1] [2] [15] [21] [23] [35] [40] [41] [57] [58] [72] [76] | [49] [58] | [54] | [41] |
| Worry, rumination or intrusive thoughts | [3] [14] [35] [40] [51] [59] [63] [71] [72] | [73] | [10] [71] | — |
| Excessive personal checking behavior | [15] [27] [35] [41] [43] [46] [57] [71] [72] [75] [76] | [49] [58] [72] | [19] | — |
| Misinterpretation of neutral bodily symptoms | [15] [40] [46] [76] | [41] | [67] | — |
| Adoption of avoidance-oriented coping | [16] [30] [35] [40] [41] [51] [63] [65] [71] [72] [76] | [35] [58] [72] | [54] | — |
| Anxious preoccupations | [1] [3] [14] [15] [43] | [46] | — | — |
| Determined by illness representation | [7] [12] [24] [37] [44] [46] [65] [66] [81] | [38] | — | — |
| Increased vigilance to somatic sensations | [40] [46] [51] | [41] | — | — |
| Ongoing, persisting and stable over time | [4] [10] [22] [27] [33] [34] [57] [59] [60] [66] [72] [75] [76] [78] | — | [61] | — |
| Multidimensional | [9] [37] [42] [78] [82] | — | — | [9] [25] [26] |
| Realistic fear | [37] [43] | — | — | — |
| Excessive concern about the treatment adverse effects | [21] [27] [44] [64] | — | — | — |
| Extra reassurance serves to maintain patients' fear | [58] [73] | — | — | — |
| Loss of a sense of security in the body | [75] | — | — | — |
| Estimation of danger enhanced by threat-related stimuli | — | [13] | — | — |
| Unrealistic fear | — | [46] [54] [58] [72] [76] | — | — |
| Autonomic arousal | — | [6] [40] [62] [73] | — | — |
| A trend decreases over time | — | [23] [38] | — | — |
| Occurs among individuals without a medical problem | — | [46] [76] | — | — |
| Experience an anxiety/relief cycle | — | [1] | — | — |
| Self-focused attention | — | — | [71] | — |
| Perceptual state that existed on a continuum changes over time | — | — | — | [27] [29] [52] [55] [80] |
| Not feeling secure and safe from danger | — | — | — | [29] |
| Internal (somatic) cues such as physical symptoms | [10] [12] [23] [24] [26] [27] [33] [44] [50] [54] [65] [66] [71] [79] | [30] [44] | [17] [19] | [27] [52] [55] [64] |
| External cues such as medical check-ups and media | [15] [21] [23] [26] [27] [33] [46] [57] [65] [72] [77] [82] | [1] | [19] | [27] [52] [55] [64] |
| Attentional and interpretation bias to threat-relevant stimuli | [6] [13] | [13] [43] | [6] [71] | |
| Cognitive vulnerability: intolerance to uncertainty | [6] [41] [65] [71] [79] | [27] | [41] | |
| Unmet information/knowledge needs | [32] | [10] [26] [52] [64] [80] | ||
| Social constraints | [11] [69] [81] | |||
| Poor problem-solving skills | [31] | |||
| Concerns about financial consequences of treatment | [62] | |||
| Decision regrets with treatment | [32] | |||
| General health worries | [17] [18] [62] | |||
| Possibility of potentially negative but uncertain future events | [17] | |||
| Inability to interpret and manage treatment-related side effects | [27] [55] [68] [80] | |||
| Not being able to rely or count on someone or something | [29] | |||
| Complexity, unpredictability, ambiguity of illness | [9] [10] [25] [26] [27] [29] [41] [55] [56] [64] [68] [75] [80] | |||
| Younger age | [4] [8] [20] [30] [33] [37] [40] [42] [67] [78] [82] | [38] [40] [62] | [61] | |
| Excessive emotional distress | [1] [3] [14] [31] [35] [43] [57] [62] [70] [78] [79] | [13] [38] | [10] [27] [29] [52] [56] [64] [80] | |
| Amount of social support | [56] [69] [81] | [27] [38] | [55] [64] [80] | |
| Appropriate self-protective response | [21] [39] [66] [73] [76] | [39] | ||
| Fear of death | [1] [5] [65] | [55] [56] [64] | ||
| Maladaptive hypervigilant coping | [3] [32] [35] [41] [43] [58] [73] [75] | [80] | ||
| Difficulties making plans for the future | [3] [15] [65] [70] | [29] [80] | ||
| Diminished health related quality of life | [2] [3] [11] [21] [22] [23] [33] [37] [43] [57] [60] [65] [67] [70] | [27] [64] | ||
| Threat appraisal | [50] [60] [66] | [61] | ||
| Functional impairments | [3] [7] [11] [21] [22] [37] [57] [58] [65] [67] [72] [77] [78] [79] | [58] [59] | ||
| Specific type of treatment | [42] [47] [67] [76] | [36] | ||
| Dysfunctional processing of fear | [57] | |||
| Chronic uncertainty | [25] [36] [39] [41] [64] | |||
| Level of self-efficacy | [82] | |||
| Cultural practices | [33] [34] [53] | |||
| Depressive symptoms | [8] [12] [58] | |||
| Associated with symptom severity | [8] | |||
| Associated with self-blame and shame | [27] | |||
| Meta-cognitive beliefs about worry | [6] [41] [54] [71] | |||
| Level of confidence | [55] | |||
| Level of anxiety | [9] [64] | |||
| Ability to register information | [25] | |||
| Short survival time | [10] [68] [80] | |||
Refer to .
Measurements: number and prevalence of thematically derived critical attributes for the four constructs: article numbers reflected in Supplementary Material.
| Focus group/semi-structured interview with open-ended questions | [1] [16] [21] [27] [39] [65] [73] [75] [77] | [1] [27] | [27] [29] [39] [55] [68] | |
| Cancer Worry Scale (CWS); Custers et al. ( | [13] [14] [15] [46] [49] [50] [76] | [61] | ||
| Assessment of Survivor Concerns (ASC) questionnaire; Gotay and Muraoka ( | [23] | [17] [23] | ||
| IES-cancer (measures cancer-specific distress: (a) Intrusive thoughts, and (b) Avoidance; Horowitz et al. ( | [63] | |||
| Study made 1 item “I worry about my cancer coming back or spreading” from 0 (not at all) to 4 (very much) | [3] [7] [62] [79] | |||
| Worry about cancer scale; Easterling and Leventhal ( | [2] [12] | |||
| Concerns about Recurrence Scale (CARS) (4 domains: worries with health, womanhood, role, and death; Vickberg ( | [5] [9] [11] [18] [25] [31] [40] [43] [45] [53] [57] [58] [59] [67] [69] [70] [78] [82] | |||
| Fear of Cancer Recurrence Inventory (FCRI) or/and | [41] [42] [67] [71] [72] [73] [74] [76] | |||
| FCRI- Subscales or Short Form (FCRI-SF); Simard and Savard ( | [6] [14] [16] [35] [44] [58] [60] [63] [69] | |||
| Fear of recurrence questionnaire; Northouse ( | [8] [24] [56] [67] | |||
| Concerns about Recurrence Questionnaire (CARQ-4); Thewes et al. ( | [20] [74] | |||
| Visual analog scale, indicating the severity of FCR | [22] [49] | |||
| Fears of cancer recurrence scale (FCR7) and short form (FCR4); Humphris et al. ( | [30] | |||
| Short form of the fear of progression questionnaire (FoP-Q-SF); Mehnert et al. ( | [37] [51] [66] | |||
| Cancer Rehabilitation Evaluation Survey—Short Form (CARES-SF); Schag et al. ( | [47] | |||
| FCR-1; Rudy et al. ( | [63] | |||
| Study made 3-items means (worry about cancer coming back in the same breast, in the other breast, and to other parts of my body) on a 5-point likert-type scale | [32] [33] [34] | |||
| Study made items survey yes/no with FCR and fear of death; Befort and Klemp ( | [4] | |||
| Study made 5-items FCR empirically derived; Xu et al. ( | [81] | |||
| Depression anxiety stress scale-21; Lovibond and Lovibond ( | [6] | |||
| Hospital Anxiety and Depression Scale (HADS); Zigmond and Snaith ( | [8] [12] [13] [14] [23] [30] [31] [35] [36] [54] [59] [60] [67] [69] | |||
| State-Trait Anxiety Inventory (STAI); Spielberger et al. ( | [9] [24] [40] [44] [48] [54] [62] [79] [82] | |||
| Profile of Mood States (POMS) tension–anxiety subscale, by McNair et al. ( | [17] | |||
| Psychological General Well-being Index (PGWB); Dupuy ( | [18] | |||
| Schedule for Affective Disorders and Schizophrenia (SADS); Spitzer and Endicott ( | [27] [28] | |||
| Generalized anxiety disorder scale; Spitzer et al. ( | [35] | |||
| Numeric visual analog scale for anxiety; Johnson et al. ( | [36] | |||
| Beck Anxiety Inventory (BAI); Beck et al. ( | [38] | |||
| Health Anxiety Questionnaire (HAQ); Lucock and Morley ( | [41] | |||
| Short Health Anxiety Inventory (SHAI); Salkovskis et al. ( | [46] | |||
| The Breast Cancer Anxiety Scale (BCAS); Kash ( | [48] [62] | |||
| Profile of Mood States-short form (POMS-SF); Shacham ( | [52] | |||
| Whiteley Index-Short Form (WI-7); Conradt et al. ( | [74] | |||
| Metacognitions Questionnaire-30; Wells and Cartwright-Hatton ( | [6] [71] | |||
| Why do people worry about health questionnaire; Pelletier et al. ( | [41] | |||
| Penn State Worry Questionnaire (PSWQ); Meyer et al. ( | [54] [58] | |||
| Illness Worry Scale (IWS); Robbins and Kirmayer ( | [67] | |||
| Study made 4 items worry about cancer; Easterling and Leventhal ( | [19] | |||
| Uncertainty in illness scale-survivor version; Mishel ( | [9] [10] [25] [26] [41] [63] [64] [80] | |||
| Cognitive Coping Strategies Questionnaire (CSQ); Rosenstiel and Keefe ( | [52] | |||
| Telephone survey assessing uncertainty triggers; Gill et al. ( | [28] | |||
Refer to .
Description of studies by location, sample size, and study design (N = 82): article numbers reflected in Supplementary Material.
| Australia | [6] [18] [71] [72] [73] [74] | 6 | 7.3 |
| New Zealand | [12] | 1 | 1.2 |
| Netherlands | [13] [14] [15] [16] [76] | 5 | 6.1 |
| Demark | [20] | 1 | 1.2 |
| German | [37] [51] | 2 | 2.4 |
| Turkey | [38] [65] | 2 | 2.4 |
| France | [44] [54] | 2 | 2.4 |
| United Kingdom | [1] [2] [28] [30] [75] | 5 | 6.1 |
| Thailand | [5] [8] [80] | 3 | 3.7 |
| Tai Wan | [21] [22] [23] | 3 | 3.7 |
| Japan | [31] [53] [57] [59] | 4 | 4.9 |
| China | [60] [81] | 2 | 2.4 |
| Korea | [66] | 1 | 1.2 |
| Canada | [40] [41] [42] [63] [67] [68] | 6 | 7.3 |
| United States | [3] [4] [7] [9] [10] [11] [17] [19] [24] [25] [26] [27] [29] [32] [33] [34] [35] [36] [39] [43] [45] [46] [47] [48] [49] [50] [52] [55] [56] [58] [61] [62] [64] [69] [70] [77] [78] [79] [82] | 39 | 47.6 |
| 1–50 | [1] [9] [16] [21] [29] [31] [36] [39] [46] [54] [55] [56] [65] [68] [70] [73] [75] [76] [77] | 19 | 23.2 |
| 51–100 | [2] [5] [6] [7] [35] [43] [44] [59] [63] [64] [81] | 11 | 13.4 |
| 101–500 | [3] [8] [10] [11] [12] [13] [15] [17] [18] [19] [20] [22] [23] [24] [25] [26] [27] [28] [30] [38] [41] [42] [45] [48] [49] [50] [53] [57] [58] [60] [61] [62] [66] [69] [71] [72] [78] [79] [80] | 39 | 47.6 |
| 501–1,000 | [4] [32] [47] [52] [67] | 5 | 6.1 |
| >1,000 | [14] [33] [34] [37] [40] [51] [74] [82] | 8 | 9.8 |
| Qualitative interviews | [1] [16] [21] [27] [28] [29] [39] [55] [65] [68] [73] [75] [77] | 13 | 15.9 |
| Instrumental validation | [14] [30] [42] [60] [63] [67] [74] [78] | 8 | 9.8 |
| Case study | [46] [54] [76] | 3 | 3.7 |
| Cross-sectional surveys | [4] [6] [7] [8] [9] [10] [11] [12] [13] [15] [18] [19] [20] [22] [24] [33] [34] [36] [37] [38] [40] [41] [44] [45] [48] [50] [51] [53] [56] [57] [58] [60] [62] [64] [66] [70] [71] [72] [80] [81] [82] | 41 | 50.0 |
| Longitudinal or prospective | [32] [47] [49] | 3 | 3.7 |
| Randomized controlled trials | [23] [25] [26] [35] [43] [52] [59] | 7 | 8.5 |
| Mixed method | [2] [69] | 2 | 2.4 |
| Other designs | [3] [5] [17] [31] [79] | 5 | 6.1 |
Refer to .
Figure 2Overlapped and distinguishing characteristics of the four constructs.
Figure 3Overlapped and distinguishing theoretical features of the four constructs.
Figure 4Overlapped and distinguishing triggers of the four constructs.
Figure 5Overlapped and distinguishing correlates of the four constructs.
Number and frequency of use of FCR, U, HA, and W Measurements.
| 73 articles examining | |
| 38 articles examining | |
| 11 articles examining | |
| 15 articles examining |
It is possible that more than one construct is examined in a single study.
Refer to .